← Leaderboards
Christopher D Nishimura
Albert Einstein College Of Medicine
$155,482
Attributed
$155,482
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2021–23$100K$75K$50K$25K$0
'21
'22
'23
Funding mix
By agency
NIH$155,482 · 1
By mechanism
F30$155,482 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Xingxing Zang$11,384,072
- Jonathan R. Lai$23,560,080
- Chandan Guha$30,646,840
- Kartik Chandran$59,376,156
- Xiaodong Wu$782,340
Others in their field
Other Emerging Leaders on “Effector T Cell”
- Tomasz Nowakowski · University Of California, San Francisco$9,024,950
- Gary Fanger · Rise Therapeutics, Llc$8,686,361
- Crystal Mackall · Children'S Hosp Of Philadelphia$7,012,524
- William Karl Decker · Baylor College Of Medicine$5,675,036
- James Even Voss · Scripps Research Institute, The$5,423,867
- Lucia N Vojtech · University Of Washington$5,251,660
Research focus
Effector T CellEnvironmentAffectAntibody ImmunotherapyCancer ImmunotherapyAnti-Pd1 AntibodiesAntitumor ResponseCancer RecurrenceCancer TherapyCd28 GeneCell CountCell PhysiologyCellsCancer ModelClinically RelevantCombination ImmunotherapyComparative EfficacyCtla4 GeneCytokineCytotoxicDifferential ExpressionDissectionEffector CellEquilibrium
Grant awards (3)
Mechanistic Dissection and Therapeutic Targeting of B7x in Cancer$52,694
F30 · FY2023 · CA · contact PI
Mechanistic Dissection and Therapeutic Targeting of B7x in Cancer$51,752
F30 · FY2022 · CA · contact PI
Mechanistic Dissection and Therapeutic Targeting of B7x in Cancer$51,036
F30 · FY2021 · CA · contact PI